1115 Results (Page 16 of 45)
Medical Devices Markets Research Reports
Italy ECG Equipments Market Analysis
Italy's ECG Equipment Market is expected to witness growth from $214 Mn in 2022 to $362 Mn in 2030 with a CAGR of 6.80% for the forecasted year 2022-30. As people in Italy become more conscious of the value of early detection and management of heart-related conditions, there is an increasing focus on preventive healthcare. Due to this, there is an increased need for ECG equipment that can be used to identify people at risk of getting heart disease. The market is segmented by product type and by end user. Some key players in this market include Progetti Srl, Esaote SpA, Johnson & Johnson, Philipps Healthcare, Medtronic, DSM N.V., Roche, and Dexcom.
Italy Coronary Stents Market Analysis
Italy's Coronary Stents Market is expected to witness growth from $271 Mn in 2022 to $378 Mn in 2030 with a CAGR of 4.25% for the forecasted year 2022-2030. Italy's growing elderly population and high prevalence of risk factors like smoking, hypertension, and diabetes are contributing to an increase in the incidence of coronary artery disease. Because of this, there is a rising need for coronary stents. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include Sorin Group, Invatec, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, and Philips Healthcare.
Italy Contraceptive Devices Market Analysis
Italy's Contraceptive Devices Market is expected to witness growth from $310 Mn in 2022 to $552 Mn in 2030 with a CAGR of 7.50% for the forecasted year 2022-30. In Italy, awareness of and demand for contraceptive techniques are growing as a result of improved access to healthcare facilities and greater educational activities. This is especially true for younger generations who are more willing to use contraceptive methods. The market is segmented by type and by gender. Some key players in this market include Farmaceutici Formenti, Dompé, Mylan Laboratories, Church & Dwight, CooperSurgical, Pfizer, Pregna International, and Teva Pharmaceutical.
Italy Cardiac Surgery Instruments Market Analysis
Italy's Cardiac Surgery Instruments Market is expected to witness growth from $50 Mn in 2022 to $80 Mn in 2030 with a CAGR of 6.10% for the forecasted year 2022-30. Ambulatory surgical facilities are becoming more popular in Italy due to their benefits, which include lower expenses, shorter hospital stays, and quicker recovery times. The need for specialized cardiac surgery instruments has grown because ambulatory surgical centers need them to perform procedures, which leads to a growth of the market for these instruments in the Italian healthcare sector. The market is segmented by type, application, and end user. Some key players in this market include Progetti Srl, Esaote SpA, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Ireland Medical Devices Market Analysis
This report presents a strategic analysis of the Ireland Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Ireland Medical Devices Market, offering unmatched value, accuracy, and expert insights.
Indonesia Pain Management Devices Market Analysis
This report presents a strategic analysis of the Indonesia Pain Management Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Indonesia Pain Management Devices Market, offering unmatched value, accuracy, and expert insights.
Indonesia ENT Devices Market Analysis
Indonesia's ENT Devices Market is projected to grow from $140 Mn in 2022 to $220 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Indonesia ENT devices market include Innonovatech Medica, Dharma Intisemesta, and Bina Medika Lestari.
Indonesia Coronary Stents Market Analysis
Indonesia's Coronary Stents Market is expected to witness growth from $68 Mn in 2022 to $98 Mn in 2030 with a CAGR of 4.75% for the forecasted year 2022-30. The older population in Indonesia is expanding and is more likely to acquire coronary heart disease. The need for coronary stents is anticipated to rise as the senior population continues to rise. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include PT. Graha Farma, PT. Mensa Bina Sukses, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, and Philips Healthcare.
Indonesia Contraceptive Devices Market Analysis
Indonesia's Contraceptive Devices Market is expected to witness growth from $77 Mn in 2022 to $143 Mn in 2030 with a CAGR of 8.00% for the forecasted year 2022-30. By 2050, the population of Indonesia is going to increase to 305 million from its current size. The need for contraceptive devices is anticipated to rise along with the population. The market is segmented by type and by gender. Some key players in this market include DKT Indonesia, Kimia Farma, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.
India ENT Devices Market Analysis
India's ENT Devices Market is projected to grow from $420 Mn in 2022 to $820 Mn by 2030, registering a CAGR of 9% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the India ENT devices market include Phoenix Medical Systems, Surgitech Innovations, and Zephyr Surgicals.
India Diabetes Devices Market Analysis
India's Diabetes Devices Market is expected to witness growth from $413 Mn in 2022 to $899 Mn in 2030 with a CAGR of 10.20% for the forecasted year 2022-30. In 2020, over 77 million adults in India have diabetes, making it one of the countries with the highest prevalence of the illness. The nation's demand for diabetes devices is anticipated to be driven by the high incidence of diabetes. The market is segmented by type and by the end user. Some key players in this market include Poly Medicure, Biosurge Healthcare, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care, and Dexcom.
India Cardiac Surgery Instruments Market Analysis
India's Cardiac Surgery Instruments Market is expected to witness growth from $38 Mn in 2022 to $78 Mn in 2030 with a CAGR of 9.60% for the forecasted year 2022-30. India has a significant incidence and prevalence of Cardiovascular Diseases (CVD), including coronary artery disease, heart failure, and hypertension. The demand for cardiac surgery equipment in the Indian healthcare industry is anticipated to rise as CVD prevalence in that country continues to rise. The market is segmented by type, application, and end user. Some key players in this market include Becton Dickinson, GPC Medical, Sahajanand Medical Technologies, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Global Cardiac Monitoring Devices Market Analysis
This report presents a strategic analysis of the Global Cardiac Monitoring Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Global Cardiac Monitoring Devices Market, offering unmatched value, accuracy, and expert insights.
Germany ENT Devices Market Analysis
Germany's ENT Devices Market is projected to grow from $850 Mn in 2022 to $1160 Mn by 2030, registering a CAGR of 4% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the German ENT devices market include Spiggle & Theis, VBM Medizintechnik, and Heinz Kurz.
Germany Coronary Stents Market Analysis
Germany's Coronary Stents Market is expected to witness growth from $414 Mn in 2022 to $522 Mn in 2030 with a CAGR of 2.95% for the forecasted year 2022-30. In Germany, a rising older demographic and an increase in risk factors like obesity and diabetes are projected to contribute to the prevalence of coronary artery disease in Germany. Coronary stent demand as a treatment option is projected to increase as a result. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include B. Braun, Biotronik, Medtronic, GE Healthcare, Boston Scientific and Philips Healthcare.
Germany Contraceptive Devices Market Analysis
Germany's Contraceptive Devices Market is expected to witness growth from $472 Mn in 2022 to $764 Mn in 2030 with a CAGR of 6.20% for the forecasted year 2022-30. The German populace is becoming more educated and aware of issues related to sexual health and contraception. The government and NGOs have taken steps to educate young people about the value of contraception, which has resulted in a rise in the use of contraceptive methods. The market is segmented by type and by gender. Some key players in this market include Riemser Arzneimittel, Femcare Medizintechnik, Bayer, Mylan Laboratories, Church & Dwight, CooperSurgical, Pfizer, Pregna International, and Teva Pharmaceutical.
France Medical Devices Market Analysis
This report presents a strategic analysis of the France Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the France Medical Devices Market, offering unmatched value, accuracy, and expert insights.
France ENT Devices Market Analysis
France's ENT Devices Market is projected to grow from $640 Mn in 2022 to $920 Mn by 2030, registering a CAGR of 4.8% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the French ENT devices market include Olympus Medical Systems, L'AC International, and Myring SAS.
France Coronary Stents Market Analysis
France's Coronary Stents Market is expected to witness growth from $311 Mn in 2022 to $417 Mn in 2030 with a CAGR of 3.75% for the forecasted year 2022-30. In France, stent installation is one of many minimally invasive procedures that are becoming more popular. The use of stents is becoming more popular because patients frequently prefer them to more invasive procedures like bypass surgery. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include Stentys, Delacroix-Chevalier, Marquat, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, and Philips Healthcare.
France Contraceptive Devices Market Analysis
France's Contraceptive Devices Market is expected to witness growth from $355 Mn in 2022 to $610 Mn in 2030 with a CAGR of 7.00% for the forecasted year 2022-30. To encourage family planning and contraception, the French government has put regulations into place, such as offering free contraception to women under the age of 25. This support is boosting the demand for contraceptive methods and opening up businesses for manufacturers. The market is segmented by type and by gender. Some key players in this market include Laboratoire CCD, HRA Pharma, Mylan Laboratories, Church & Dwight, CooperSurgical, Pfizer, Pregna International, and Teva Pharmaceutical.
Europe Coronary Stents Market Analysis
This report presents a strategic analysis of the European coronary Stents Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the European coronary Stents Market, offering unmatched value, accuracy, and expert insights.
Egypt ENT Devices Market Analysis
Egypt's ENT Devices Market is projected to grow from $60 Mn in 2022 to $110 Mn by 2030, registering a CAGR of 7.3% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Egypt ENT devices market include Alfa Medical, Al Amal Medical Supplies, and Misr Medicare.
Egypt Diabetes Devices Market Analysis
Egypt's Diabetes Devices Market is expected to witness growth from $64 Mn in 2022 to $124 Mn in 2030 with a CAGR of 8.70% for the forecasted year 2022-2030. As healthcare expenditures in Egypt increase, a greater focus is being placed on preventive care and the management of chronic diseases. The demand for healthcare goods in general, including diabetes management devices, ought to increase as a result. The market is segmented by type and by the end user. Some key players in this market include JK Medirise, EGMED, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care, and Dexcom.
Egypt Coronary Stents Market Analysis
Egypt's Coronary Stents Market is expected to witness growth from $32 Mn in 2022 to $51 Mn in 2030 with a CAGR of 6.25% for the forecasted year 2022-30. Increased investment in infrastructure, energy, and industry has contributed to Egypt's recent rapid economic expansion. This expansion offers manufacturers the chance to build their companies and enter new markets. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include JK Medirise, EGMED, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, and Philips Healthcare.
Egypt Contraceptive Devices Market Analysis
Egypt's Contraceptive Devices Market is expected to witness growth from $36 Mn in 2022 to $75 Mn in 2030 with a CAGR of 9.50% for the forecasted year 2022-30. Egypt's contemporary contraceptive prevalence rate reached 49.4% in 2020, although there is still tremendous space for market expansion. The market is segmented by type and by gender. Some key players in this market include Eva Pharma, Delta Pharma, Amoun Pharmaceutical, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, Pregna International, and Teva Pharmaceutical.